Research On The Motivation And Performance Of Xinkaiyuan’s Overseas Mergers And Acquisition Of BioVision

The high speed development of economy to a huge increase,the people’s standard of living but with the present and future the deepening of the aging population of our country,and people’s desire for the high quality level of economic life has become increasingly intense,and increasingly attention to body health,willing to pay health costs increase year by year,but in precision medical industry chain is not perfect,Diagnostic reagent technology is monopolized by overseas,which affects the healthy development of precision medicine industry and cannot better meet the needs of consumers.Moreover,diagnostic reagent technology is difficult to form in a short period of time.Therefore,it is a life-saving straw for enterprises to upgrade the industrial structure through overseas acquisition and other epitaxial expansion strategies.Overseas M＆A can truly solve the industry development problems,improve the core competitiveness of the acquirer,and generate synergistic effects.For example,the cooperation between the two parties can continuously produce new products or technologies,so as to make the overall sustainable development of the enterprise,which is exactly what this paper needs to verify.Since it is rare to study the M＆A behavior in precision medicine industry from a single case,this paper mainly adopts the case study method to analyze the case of the XKY overseas acquisition of BV.First of all,the detailed introduction of the process of M＆A events and the background of both parties is conducive to a comprehensive understanding of the purpose of the actions of both parties,which lays a foundation for the motivation analysis and performance analysis.Secondly,SWOT analysis method is used to analyze the motivation of the new open source M＆A behavior from the advantages,disadvantages,opportunities and threats,and determine the purpose of M＆A behavior.The main feature of the balanced scorecard analysis method is that it is analyzed from the perspective of both financial and non-financial,and the positive and negative effects of M＆A events on all aspects of corporate performance can be intuitively seen.In this paper,it is concluded that in the ever-changing market environment,the main purpose of NKY’s M＆A is to improve the precision medical industry chain,generate synergies and improve the overall profitability of the enterprise.After the acquisition of BV by the new open source,the results obtained by using the balanced scorecard analysis method can be seen that the overall performance of the enterprise is improved.Therefore,this paper concludes that the M＆A behavior of New Open source is successful,which has realized the original purpose of M＆A and is conducive to the long-term development of enterprises.The success of the new open source reveals us that a successful M＆A needs to do: M＆A behavior should conform to the enterprise strategy;Full investigation and forecast should be carried out before merger and acquisition;After the merger and acquisition,we need to implement the merger and integration plan.